FORMULE B-13
Natural health product licensed in Canada
- Other names
- Formule C-13
- Licence holder
- Les Herbages Normex Ltée
- NPN or DIN-HM
- 00459674
- Status
- Active licence
- Licence date
- 27 October 2009
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tilia europaea Source : Fleur Extraction ratio : 1:4 Dry plant equivalent : 64 mg | 16 mg | Not calculated |
| Eucalyptus globulus Source : Plante entière Extraction ratio : 1:4 Dry plant equivalent : 32 mg | 8 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine | 16 mg | Not calculated |
| Papaver rhoeas Source : Fleur | 16 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium végétal, acacia, Sucre à glacer, Bourdaine, Lactose, Amidon, Mélisse
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Expectorant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 00459674
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.